Urol. praxi, 2011; 12(5): 292-294

Prostate cancer radiotherapy - related complications, their prevention and treatment

MUDr.Irena Čoupková, MUDr.Petr Čoupek, MUDr.Pavel Krupa, prof.MUDr.Pavel Šlampa, CSc.
Klinika radiační onkologie LF MU, Masarykův onkologický ústav, Brno

Radiotherapy for prostate cancer is connected with urinary and gastrointestinal toxicity. We distinguish two types of adverse effects: early

(acute) and late (chronic). In the course of radiotherapy and shortly after the treatment completion we can expect intestinal frequency,

tenesmus, diarrhoea, rectal bleeding, pollakisuria, dysuria, acute urinary retention and hematuria. Late sequelae of radiotherapy originate

several months till years after the treatment and manifest as postradiation proctitis and cystitis, rectal a urethral strictures, ulcers,

bowel obstruction and perforation and fistulae. 40–50 % patiens with prostate cancer treated with external beam radiation therapy

have erectile dysfunction. Patient co-operation and régime and dietary arrangements are important in prevention of postradiation

complications. Treatment of less serious complications is symptomatic, serious acute and late sequelae of treatment are subjekt matter

for gastroenterologist and urologist.

Keywords: prostata cancer, radiotherapy, sequelae of radiotherapy

Published: November 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čoupková I, Čoupek P, Krupa P, Šlampa P. Prostate cancer radiotherapy - related complications, their prevention and treatment. Urol. praxi. 2011;12(5):292-294.
Download citation

References

  1. Halperin EC, Perez CA, Brady LW. Principles and practice of radiation oncology 2008; 1471-1475.
  2. Zelefsky MJ, Yamada Y, Fuks Z, et al. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 2008; 71(4): 1028-1033. Go to original source... Go to PubMed...
  3. Jereczek-Fossa BA, Zerini D, Fodor K, et al. Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy. Int J Radiat Oncol Biol Phys 2010; 78(1): 26-34. Go to original source... Go to PubMed...
  4. Choe KS, Jani AB, Liauw SL. External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity? Int J Radiat Oncol Biol Phys 2010; 76(3): 755-760. Go to original source... Go to PubMed...
  5. Odrážka K, Vaňásek J, Vaculíková M, Zouhar M, Kadečka D. Konformní versus konvenční radioterapie karcinomu prostaty: dozimetrické porovnání s využitím objemových histogramů. Klin Onkol 1999; 12(2): 61-65.
  6. Odrážka K, Vaculíková M, Petera J, a kol. Akutní toxicita provázející konformní radioterapii karcinomu prostaty. Klin Onkol 2002; 15(2): 58-63.
  7. Soumarová R, Homola L, Štursa M, Perková H. Srovnání akutní toxicity trojrozměrné konformní zevní radioterapie a kombinace zevní radioterapie s vysokodávkovanou (HDR) brachyterapií u lokalizovaného karcinomu prostaty. Klin Onkol 2006; 19(1): 19-25.
  8. Odrážka K, Vaculíková M, Doležel M, a kol. Chronická toxicita trojrozměrné konformní radioterapie (3D-CRT) karcinomu prostaty. Klin Onkol 2006; 19(4): 222-227.
  9. Šlampa P, a kol. Radiační onkologie v praxi. Druhé aktualizované vydání 2007; 140-151.
  10. Šlampa P, Petera J, a kol. Radiační onkologie 2007; 287-297.
  11. Šefrová J, Paluska P, Odrážka K, Jirkovský V. Chronická gastrointestinální toxicita po zevní radioterapii karcinomu prostaty. Klin Onkol 2009; 22(5): 233-241. Go to PubMed...
  12. Odrážka K, Doležel M, Vaňásek J. Moderní metody zevní radioterapie v léčbě karcinomu prostaty. Ces Urol 2010; 14(2): 81-91.
  13. Odrážka K, Doležel M, Vaňásek J, a kol. Chronická urinární toxicita 3D-CRT a IMRT karcinomu prostaty. Ces Urol 2010; 14(3): 156-163.




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.